Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2025-11-05 00:00:00 ET · period of report 2025-11-03 · accession 0001193125-25-267467 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-11-05 | 2025-11-03+ | AXSM | TABUTEAU HERRIOT | CEO, Dir, 10% | S - Sale+OE | $133.07 | -163.9K | 7,229 | -96% | -$21.82M |
| DMT | 2025-11-05 | 2025-11-03+ | AXSM | TABUTEAU HERRIOT | CEO, Dir, 10% | M - OptEx | $8.02 | +163.9K | 98.9K | New | +$1.31M |
| DMT | 2025-11-05 | 2025-11-03+ | AXSM | TABUTEAU HERRIOT | CEO, Dir, 10% | M - OptEx | $0.00 | -163.9K | 324.0K | -34% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-05 | S | D | 21,775 | $134.49 | 7,229 | D | — | — | (F6) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $131.60 and $135.49. |
| 2 | Common | Common Stock | 2025-11-05 | M | A | 21,775 | $8.02 | 29,004 | D | — | — | |
| 3 | Common | Common Stock | 2025-11-04 | S | D | 50,459 | $133.79 | 7,229 | D | — | — | (F5) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $131.50 and $135.90. |
| 4 | Common | Common Stock | 2025-11-04 | M | A | 50,459 | $8.02 | 57,688 | D | — | — | |
| 5 | Common | Common Stock | 2025-11-03 | S | D | 91,705 | $132.34 | 7,229 | D | — | — | (F4) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $124.16 and $137.59. |
| 6 | Common | Common Stock | 2025-11-03 | M | A | 91,705 | $8.02 | 98,934 | D | — | — | |
| 7 | Derivative | Stock Option (Right to Buy) | 2025-11-04 | M | D | 50,459 | $0.00 | 273,572 | D | $133.79 · 2017-05-27 to 2026-05-27 | 50,459 Common Stock | |
| 8 | Derivative | Stock Option (Right to Buy) | 2025-11-05 | M | D | 21,775 | $0.00 | 251,797 | D | $134.49 · 2017-05-27 to 2026-05-27 | 21,775 Common Stock | |
| 9 | Derivative | Stock Option (Right to Buy) | 2025-11-03 | M | D | 91,705 | $0.00 | 324,031 | D | $132.34 · 2017-05-27 to 2026-05-27 | 91,705 Common Stock |